We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.89%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$2.68B
AUM Growth
+$730M
(+37%)
Cap. Flow
+$634M
Cap. Flow
% of AUM
23.64%
Top 10 Holdings %
Top 10 Hldgs %
78.07%
Holding
230
New
82
Increased
28
Reduced
42
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLUE
bluebird bio
BLUE
|
+$9.12M |
| 2 |
Aspen Aerogels
ASPN
|
+$6.41M |
| 3 |
CTAC
Cerberus Telecom Acquisition Corp.
CTAC
|
+$6.22M |
| 4 |
QUOT
Quotient Technology Inc
QUOT
|
+$6.18M |
| 5 |
Enovix
ENVX
|
+$5.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$11.1M |
| 2 |
CareDx
CDNA
|
+$10.1M |
| 3 |
Neuronetics
STIM
|
+$8.13M |
| 4 |
Axogen
AXGN
|
+$7.95M |
| 5 |
PayPal
PYPL
|
+$5.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.79% |
| 2 | Consumer Discretionary | 1.99% |
| 3 | Technology | 1.3% |
| 4 | Communication Services | 1.2% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Establishment Labs
ESTA
$2.32B
| $1.68M | 0.06% |
26,800
-23,200
| -46% | -$1.34M |
|
|
SPRB
102
Spruce Biosciences
SPRB
$129M
| $1.66M | 0.06% |
1,333
| – | – |
|
103
RingCentral
RNG
$5.34B
| $1.65M | 0.06% |
5,525
| – | – |
|
104
Ranpak Holdings
PACK
$475M
| $1.6M | 0.06% |
+80,000
| New | +$1.49M |
|
105
Apple
AAPL
$4.57T
| $1.59M | 0.06% |
13,000
| – | – |
|
|
FTOC
106
DELISTED
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
| $1.59M | 0.06% |
+150,000
| New | +$1.76M |
|
|
KIN
107
DELISTED
Kindred Biosciences, Inc.
KIN
| $1.58M | 0.06% |
+317,929
| New | +$1.54M |
|
108
Tandem Diabetes Care
TNDM
$1.48B
| $1.56M | 0.06% |
17,708
-12,292
| -41% | -$1.14M |
|
109
Bank of America
BAC
$441B
| $1.55M | 0.06% |
40,000
| – | – |
|
110
Forte Biosciences
FBRX
$1.57B
| $1.51M | 0.06% |
1,760
| – | – |
|
111
InflaRx
IFRX
$272M
| $1.49M | 0.06% |
+381,086
| New | +$1.95M |
|
|
NBIS
112
Nebius Group N.V.
NBIS
$47B
| $1.47M | 0.06% |
23,000
-35,000
| -60% | -$2.34M |
|
113
CALL
Amplify Alternative Harvest ETF
MJ
$105M
| $1.47M | 0.05% |
5,358
-8,334
| -61% | -$2.2M |
|
114
Wolfspeed
WOLF
$1.64B
| $1.41M | 0.05% |
13,000
-2,000
| -13% | -$225K |
|
115
Newmont
NEM
$118B
| $1.33M | 0.05% |
22,000
| – | – |
|
|
EVAX
116
Evaxion A/S
EVAX
$24.8M
| $1.32M | 0.05% |
+4,492
| New | +$1.72M |
|
117
Passage Bio
PASG
$14.6M
| $1.31M | 0.05% |
+3,750
| New | +$1.6M |
|
118
Katapult Holdings
KPLT
$33M
| $1.31M | 0.05% |
4,000
+2,400
| +150% | +$927K |
|
|
LNW
119
DELISTED
Light & Wonder
LNW
| $1.31M | 0.05% |
34,000
-36,000
| -51% | -$1.61M |
|
120
Xenon Pharmaceuticals
XENE
$6.13B
| $1.25M | 0.05% |
70,000
-69,360
| -50% | -$1.18M |
|
121
CALL
Weibo
WB
$1.95B
| $1.24M | 0.05% |
24,600
+11,300
| +85% | +$570K |
|
122
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.55B
| $1.22M | 0.05% |
+15,000
| New | +$1.14M |
|
123
New Oriental
EDU
$8.93B
| $1.12M | 0.04% |
8,000
+1,000
| +14% | +$175K |
|
|
MGI
124
DELISTED
MoneyGram International, Inc. New
MGI
| $1.12M | 0.04% |
170,000
+36,125
| +27% | +$265K |
|
125
B2Gold
BTG
$6.72B
| $1.08M | 0.04% |
250,000
| – | – |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Granite Point Capital Management held 230 positions worth $2.68B, up 37% from $1.95B the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Granite Point Capital Management deployed $634M of net new capital in Q1 2021, opening 82 new positions and adding to 28 existing holdings. Its largest new stake was bluebird bio: 18,528 shares worth $7.24M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, down from 4.3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Neuronetics, an estimated $8.13M trimmed.
- Granite Point Capital Management's largest Q1 2021 buy was bluebird bio: 18,528 shares worth $7.24M.
- Granite Point Capital Management added most to Baidu in Q1 2021, an estimated $4.7M increase.
- Granite Point Capital Management's biggest Q1 2021 reduction was Neuronetics, cutting an estimated $8.13M.
- Granite Point Capital Management fully exited DraftKings in Q1 2021, selling an estimated $11.1M.
- Granite Point Capital Management's ten largest holdings make up 78% of its $2.68B portfolio in Q1 2021.
- Granite Point Capital Management opened 82 new positions and closed 51 in Q1 2021.
- Granite Point Capital Management's portfolio value rose 37% quarter-over-quarter to $2.68B.
Based on Granite Point Capital Management's 13F filing for Q1 2021, filed 12 May 2021.